Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus cognitive behavioural therapy for persistent generalized anxiety disorder after failed low-intensity psychological interventions
2014-004077-16Phase 4Terminated
- Sponsor
- University College London
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sertraline in generalized anxiety disorder (GAD) (2 arms), sponsored by University College London. Primary endpoint: Generalized Anxiety Disorder 7-item scale. Started Jul 2015; status: terminated.
02
Drugs
sertraline
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2014-004077-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004077-16.